Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Akamai Technologies, Inc. (AKAM)’s CEO Buys Stock Amid M&A Announcement

IT services company Akamai Technologies, Inc. (NASDAQ:AKAM)’s Chief Executive Officer Thomson F Leighton bought 25,000 shares of the company last week, at an average price of $45.28 per share. He now owns more than 3 million units of common stock valued at more than $135 million.

The acquisition followed an important announcement made last Monday (Dec. 2nd): the company will acquire Prolexic, “a provider of cloud-based security solutions for protecting data centers and enterprise IP applications from distributed denial of service (DDoS) attacks.” Through this purchase, the web security and optimization provider seeks to expand its portfolio of cloud-based enterprise and data center security solutions.

Akamai Technologies, Inc. (NASDAQ:AKAM)

Nonetheless, the insider has perceived some downside since his purchase. The stock crossed below its 200 day moving average of $44.18, today, Monday. The drop follows Verizon Communications Inc. (NYSE:VZ)’s decision of to acquire EdgeCast, one of Akamai Technologies, Inc. (NASDAQ:AKAM)’s main competitors. Nonetheless, the market seems to have overreacted: Wells Fargo analyst Gray Powell stated, in a note to investors, that the impact of this purchase over Akamai’s overall profitability should be limited, even though Verizon Wireless is an Akamai customer, as it probably does not account for more than 1% of the IT services company´s revenue.

One way or another, Leighton will most likely not care about this slight price fluctuation. In fact, Akamai Technologies, Inc. (NASDAQ:AKAM)’s CEO seems to be betting on the company’s long term results. As global cyber security spending continues to increase, this firm’s wide portfolio should help it seize big opportunities. The company is not only investing in M&A, but also on R&D, and on expanding its sales force, getting ready for a demand bound to rocket.

But Leighton is not the only one placing bets on Akamai. At least 30 of the major hedge funds that we track hold long positions in the company. Amongst them we should highlight Clifton S. Robbins‘ Blue Harbour Group –the biggest institutional bull- that owns more than $165 million in shares, which account for about 12% of its portfolio. Other prominent bulls worth mentioning are Ken Griffin‘s Citadel Investment Group, with $43 million in shares, and Panayotis Takis Sparaggis Alkeon Capital Management, which holds almost $80 million worth of stock.

The stock of Akamai trades at 29 times its earnings, which represents a 40% discount to its industry’s average, while offering wide margins and returns. If insiders and funds are placing big stakes on this IT company with almost $8 billion in market cap, should you too?

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Insiders Feeling Good With These Healthcare Stocks

Insiders and Jim Simons Into IT Services

Why Are Insiders Betting on These Distressed Communication Equipment Stocks

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.